GANYMED PHARMACEUTICALS AG;TRON—Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz gemeinnützige GmbH
发明人:
Ugur Sahin,Özlem Türeci,Rita Mitnacht-Kraus,Stefan Denis Jacobs,Magdalena Jadwiga Utsch,Cornelia Adriana Maria Heinz,Christiane Regina Stadler
申请号:
US14401557
公开号:
US09433675B2
申请日:
2013.05.21
申请国别(地区):
US
年份:
2016
代理人:
摘要:
The present invention provides a combination therapy for effectively treating and/or preventing diseases associated with cells expressing CLDN18.2, including cancer diseases such as gastric cancer, esophageal cancer, pancreatic cancer, lung cancer, ovarian cancer, colon cancer, hepatic cancer, head-neck cancer, and cancer of the gallbladder and metastases thereof.